These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 34284174)
1. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. Deng Y; Zheng Y; Li D; Hong Q; Zhang M; Li Q; Fu B; Wu L; Wang X; Shen W; Zhang Y; Chang J; Song K; Liu X; Shang S; Cai G; Chen X EBioMedicine; 2021 Aug; 70():103477. PubMed ID: 34284174 [TBL] [Abstract][Full Text] [Related]
2. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus. Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909 [TBL] [Abstract][Full Text] [Related]
3. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice. Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550 [TBL] [Abstract][Full Text] [Related]
4. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis. Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738 [TBL] [Abstract][Full Text] [Related]
5. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus. Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T Front Immunol; 2022; 13():962393. PubMed ID: 35967341 [TBL] [Abstract][Full Text] [Related]
6. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9. Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522 [TBL] [Abstract][Full Text] [Related]
7. Identification of NET formation and the renoprotective effect of degraded NETs in lupus nephritis. Jin Y; Wang Y; Ma X; Li H; Zhang M Am J Physiol Renal Physiol; 2024 Oct; 327(4):F637-F654. PubMed ID: 39205658 [TBL] [Abstract][Full Text] [Related]
8. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus. Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE. Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415 [TBL] [Abstract][Full Text] [Related]
12. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation. Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567 [TBL] [Abstract][Full Text] [Related]
13. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624 [TBL] [Abstract][Full Text] [Related]
14. Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus. Hu H; Chen E; Li Y; Zhu X; Zhang T; Zhu X Biol Trace Elem Res; 2018 Aug; 184(2):391-397. PubMed ID: 29159556 [TBL] [Abstract][Full Text] [Related]
15. Imbalance of programmed cell death patterns mediated by dendritic cell subsets in systemic lupus erythematosus and lupus nephritis. Xu R; Zhang Y; Cao Q; Liao S; Tang Y; Zhuang Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):331-348. PubMed ID: 38970507 [TBL] [Abstract][Full Text] [Related]
16. Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway. Yang L; Zhang T; Wang P; Chen W; Liu W; He X; Zhang Y; Jin S; Luo Z; Zhang Z; Wang X; Liu J Cell Biol Toxicol; 2023 Dec; 39(6):3287-3304. PubMed ID: 37804401 [TBL] [Abstract][Full Text] [Related]
17. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice. Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N Front Immunol; 2021; 12():653989. PubMed ID: 33868295 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of gene expression profiles of peripheral blood cells in systemic lupus erythematosus. Bae SC; Lee YH Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):40-49. PubMed ID: 30084812 [TBL] [Abstract][Full Text] [Related]
19. Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus. Mistry P; Nakabo S; O'Neil L; Goel RR; Jiang K; Carmona-Rivera C; Gupta S; Chan DW; Carlucci PM; Wang X; Naz F; Manna Z; Dey A; Mehta NN; Hasni S; Dell'Orso S; Gutierrez-Cruz G; Sun HW; Kaplan MJ Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25222-25228. PubMed ID: 31754025 [TBL] [Abstract][Full Text] [Related]
20. Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation. Marczynski P; Meineck M; Xia N; Li H; Kraus D; Roth W; Möckel T; Boedecker S; Schwarting A; Weinmann-Menke J Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]